Loading...
 
Back to the list
Mediterr J Rheumatol 2016;27(3):132-4
Article Links
Genetics in Sjögren’s syndrome-related lymphomagenesis
Clio P. Mavragani
Authors Information

Departments of Physiology and Pathophysiology, National and Kapodistrian University of Athens, Greece

Keywords: Sjögren’s syndrome, B-cell activating factor, Methylation alterations, Genetic factors
References
  1. Kassan S S, Moutsopoulos H M. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164:1275-84.
  2. Smedby K E, Hjalgrim H, Askling J, Chang E T, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006;98:51-60.
  3. Tapinos N, Polihronis M, Moutsopoulos H M.  Lymphoma development in primary Sjögren's Syndrome. Arthritis Rheum 1999;7:1466-72.
  4. Pisa E K, Pisa P, Kang H I, Fox R I.  High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients. J Exp Med 1991;174:1245-50.
  5. Mavragani C P, Niewold T B, Moutsopoulos N M, Pillemer S R, Wahl S M, Crow M K. Augmented interferon-alpha pathway activation in patients with Sjögren’s syndrome treated with etanercept. Arthritis Rheum 2007;56:3995-4004.
  6. Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren’s syndrome. J Pathol 2004;202:496-502
  7. Fye J M, Orebaugh C D, Coffin S R, Hollis T, Perrino F W. Dominant mutation of the TREX1 exonuclease gene in lupus and Aicardi-Goutieres syndrome. J Biol Chem 2011;286:32373-82.
  8. Peschke K, Friebe F, Zimmermann N, Wahlicht T, Schumann T, Achleitner M, et al. Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J Invest Dermatol 2014;134:1456-9.
  9. Namjou B, Kothari P H, Kelly J A, Glenn S B, Ojwang JO, Adler A, et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011;12:270-9.
  10. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 2002;3:424-9
  11. Nossent J C, Lester S, Zahra D, Mackay C R, Rischmueller M. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjögren’s syndrome. Rheumatology (Oxford) 2008;47:1311-6.
  12. Nezos A, Papageorgiou A, Fragoulis G, Ioakeimidis D, Koutsilieris M, Tzioufas A G, et al.  B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjögren’s syndrome. J Autoimmun 2014;51:89-98.
  13. Papageorgiou A, Mavragani C P, Nezos A, Zintzaras E, Quartuccio L, De Vita S, et al. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation. Arthritis Rheumatol 2015;67:2732-41.
  14. Hildebrand J M, Luo Z, Manske M K, Price-Troska T, Ziesmer S C, Lin W, et al. A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J Exp Med 2010;207:2569-79.
  15. Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood 2013;122:4068-76.
  16. Zhang X, Li W, Zhang X, Zhao L, Zhang X, Jiang L, et al. Single nucleotide polymorphisms in TNFAIP3 were associated with the risks of rheumatoid arthritis in northern Chinese Han population. BMC Med Genet 2014;15:5.
  17. Du Y, Su Y, He J, Yang Y, Shi Y, Cui Y, et al. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome. Ann Rheum Dis 2015;74:2070-5. 
  18. Low H Z, Reuter S, Topperwien M, Dankenbrink N, Peest D, Kabalak G, et al. Association of the LILRA3 deletion with B-NHL and functional characterization of the immunostimulatory molecule. PLoS One 2013;8:e81360.
  19. Du Y, Cui Y, Liu X, Hu F, Yang Y, Wu X, et al.Contribution of functional LILRA3, but not nonfunctional LILRA3, to sex bias in susceptibility and severity of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014;66:822-30.
  20. An H, Chandra V, Piraino B, Borges L, Geczy C, et al. Soluble LILRA3, a potential natural anti-inflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma. J Rheumatol 2010;37:1596-606.
  21. Kabalak G, Dobberstein S B, Matthias T, Reuter S, The Y H, Dörner T, et al. Association of immunoglobulin-like transcript 6 deficiency with Sjögren's syndrome. Arthritis Rheum 2009;60:2923-5.
  22. Gemmati D, Ongaro A, Scapoli G L, Della Porta M, Tognazzo S, Serino M L, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non Hodgkin’s lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004;13:787-94.
  23. Skibola C F, Forrest M S, Coppedé F, Agana L, Hubbard A, Smith M T, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155-62.
  24. Altorok N, Coit P, Hughes T, Koelsch K A, Stone D U, Rasmussen A, et al. Genome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome. Arthritis Rheumatol 2014;66:731-9.
  25. Mavragani C P, Patronas N, Dalakas M, Moutsopoulos H M. Ill-defined neurological syndromes with autoimmune background: a diagnostic challenge. J Rheumatol 2007;34:341-5.
  26. Rubini M, Padovan M, Baricordi O, Fotinidi M, Govoni M, Trotta F. The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients. Clin Exp Rheumatol 2008;26:163.